Retour aux projets

15610.1 PFLS-LS

15610.1 PFLS-LS

Résumé

Development of a recently validated cell penetrating peptide into an efficacious therapeutic cancer vaccine

Textes supplémentaires

Abstract

Therapeutic cancer vaccines are becoming an attractive approach that can be combined with standard of care to treat cancer patients. The patient immune system is educated to specifically recognize and destroy tumor cells. This project aims at designing and optimizing an immunization strategy for a new cancer vaccine including the vector, the antigen and the choice of adjuvant. Finally, the proof-of-concept will be performed in a murine model of brain tumors.

Participants

Madiha Derouazi

Wirtschaftspartner

madiha.derouazi@amaltherapeutics.com

Amal Therapeutics SA Madiha Derouazi Avenue de la Roseraie 64 1205 Genève GE CH

Paul Walker

Kontaktperson

Paul.Walker@hcuge.ch

Université de Genève Paul Walker Rue Gabrielle-Perret-Gentil 4 1211 Genève GE CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2013-07-31
Date de fin
2015-10-31
Coûts totaux approuvés
CHF 488704.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%